Study of Medication and Placebo Response in Major Depression

Completed · Phase 4

Conditions studied: Depressive Disorder, Major

In brief

The primary purpose of the research study is to use recordings of brain electrical activity (through electroencephalogram, or EEG) and symptom measurements to determine whether patients are likely to show a response to medication or placebo treatment during a treatment trial for depression.

Key facts

Study ID

NCT00229476

Run by

University of California, Los Angeles

People needed

60

Starts

2003-12-01

Last updated by the study team

2016-11-07

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical Diagnosis of Unipolar Major Depression

You may not qualify if…

• Substance Abuse, Psychotic Disorder, History of Severe Head Trauma

Where it is running

• UCLA Neuropsychiatric Institute & Hospital — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.